Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Fairlie

Showing results (111-120 of 326) with videos related to

Pageof 33
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 19, 2010
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID componentsNicole C Wheatley, Katherine T Andrews, Truc L Tran, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 19, 2019
Computer Modelling and Synthesis of Deoxy and Monohydroxy Analogues of a Ribitylaminouracil Bacterial Metabolite that Potently Activates Human T CellsGeraldine J M Ler, Weijun Xu, Jeffrey Y W Mak, et al.
The Journal of Surgical Research|January 21, 2004
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in ratsTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Journal of Medicinal Chemistry|March 19, 2004
Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial librariesRobert C Reid, Leonard K Pattenden, Joel D A Tyndall, et al.
The Journal of Surgical Research|April 2, 2002
Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestineThiruma V Arumugam, Ian A Shiels, Trent M Woodruff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2017
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer CellsYuhong Jiang, Mei-Kwan Yau, Junxian Lim, et al.
Inorganic Chemistry|September 16, 2008
Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformationHuy N Hoang, Gavin K Bryant, Michael J Kelso, et al.
Journal of Medicinal Chemistry|May 9, 2020
Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell ProliferationJiahui Tng, Junxian Lim, Kai-Chen Wu, et al.
Bioconjugate Chemistry|June 1, 2017
Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a ReceptorAline Dantas de Araujo, Chongyang Wu, Kai-Chen Wu, et al.
Journal of Medicinal Chemistry|September 12, 2009
Structure-activity relationships for substrate-based inhibitors of human complement factor BGloria Ruiz-Gómez, Junxian Lim, Maria A Halili, et al.
Pageof 33

Showing results (111-120 of 326) with videos related to

Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry Letters|October 19, 2010
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID componentsNicole C Wheatley, Katherine T Andrews, Truc L Tran, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 19, 2019
Computer Modelling and Synthesis of Deoxy and Monohydroxy Analogues of a Ribitylaminouracil Bacterial Metabolite that Potently Activates Human T CellsGeraldine J M Ler, Weijun Xu, Jeffrey Y W Mak, et al.
The Journal of Surgical Research|January 21, 2004
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in ratsTrent M Woodruff, Thiruma V Arumugam, Ian A Shiels, et al.
Journal of Medicinal Chemistry|March 19, 2004
Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial librariesRobert C Reid, Leonard K Pattenden, Joel D A Tyndall, et al.
The Journal of Surgical Research|April 2, 2002
Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestineThiruma V Arumugam, Ian A Shiels, Trent M Woodruff, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2017
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer CellsYuhong Jiang, Mei-Kwan Yau, Junxian Lim, et al.
Inorganic Chemistry|September 16, 2008
Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformationHuy N Hoang, Gavin K Bryant, Michael J Kelso, et al.
Journal of Medicinal Chemistry|May 9, 2020
Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell ProliferationJiahui Tng, Junxian Lim, Kai-Chen Wu, et al.
Bioconjugate Chemistry|June 1, 2017
Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a ReceptorAline Dantas de Araujo, Chongyang Wu, Kai-Chen Wu, et al.
Journal of Medicinal Chemistry|September 12, 2009
Structure-activity relationships for substrate-based inhibitors of human complement factor BGloria Ruiz-Gómez, Junxian Lim, Maria A Halili, et al.
Pageof 33